Tumor angiogenesis and endothelial cell modulatory factors

Sudhen B. Desai, Steven K. Libutti

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Angiogenesis is the ability of preexisting vasculature to send out capillary sprouts leading to the formation of new vasculature. It is now a well-accepted idea that progression of solid tumors is intrinsically dependent on angiogenesis for growth of the primary tumor and metastatic lesions. Investigations into tumor angiogenesis have focused on inhibition of tumor neovasculature as yet another possible mechanism for impairing tumor progression. Numerous studies have characterized cellular and molecular factors important to vascular formation and development and have led to the identification and understanding of requisite interactions between endothelium, angiogenic cytokines, and the supporting matrix. These studies have also led to the identification of cytokines involved in the proteolytic disruption of the basement membrane, the migration of endothelial cells, and the proliferation and formation of neoendothelium into functional vasculature. As therapies based on antiangiogenic strategies continue to evolve and clinical trials are conducted, these agents may become an important part of the arsenal against tumor proliferation, especially given their favorable toxicity profile. This review discusses the angiogenic cytokines which have been most intensely studied and the receptors they act upon. Additionally, we discuss select proteases and their importance in the development of neovasculature. A better understanding of these components will help in the development of novel therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)186-211
Number of pages26
JournalJournal of Immunotherapy
Volume22
Issue number3
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Endothelial Cells
Neoplasms
Cytokines
Basement Membrane
Endothelium
Blood Vessels
Peptide Hydrolases
Cell Proliferation
Clinical Trials
Therapeutics
Growth

Keywords

  • Endothelial cells
  • Neovasculature
  • Tumor angiogenesis

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Immunology

Cite this

Tumor angiogenesis and endothelial cell modulatory factors. / Desai, Sudhen B.; Libutti, Steven K.

In: Journal of Immunotherapy, Vol. 22, No. 3, 1999, p. 186-211.

Research output: Contribution to journalArticle

Desai, Sudhen B. ; Libutti, Steven K. / Tumor angiogenesis and endothelial cell modulatory factors. In: Journal of Immunotherapy. 1999 ; Vol. 22, No. 3. pp. 186-211.
@article{7f464fda5c234a63b9cea8d966ea5268,
title = "Tumor angiogenesis and endothelial cell modulatory factors",
abstract = "Angiogenesis is the ability of preexisting vasculature to send out capillary sprouts leading to the formation of new vasculature. It is now a well-accepted idea that progression of solid tumors is intrinsically dependent on angiogenesis for growth of the primary tumor and metastatic lesions. Investigations into tumor angiogenesis have focused on inhibition of tumor neovasculature as yet another possible mechanism for impairing tumor progression. Numerous studies have characterized cellular and molecular factors important to vascular formation and development and have led to the identification and understanding of requisite interactions between endothelium, angiogenic cytokines, and the supporting matrix. These studies have also led to the identification of cytokines involved in the proteolytic disruption of the basement membrane, the migration of endothelial cells, and the proliferation and formation of neoendothelium into functional vasculature. As therapies based on antiangiogenic strategies continue to evolve and clinical trials are conducted, these agents may become an important part of the arsenal against tumor proliferation, especially given their favorable toxicity profile. This review discusses the angiogenic cytokines which have been most intensely studied and the receptors they act upon. Additionally, we discuss select proteases and their importance in the development of neovasculature. A better understanding of these components will help in the development of novel therapeutic strategies.",
keywords = "Endothelial cells, Neovasculature, Tumor angiogenesis",
author = "Desai, {Sudhen B.} and Libutti, {Steven K.}",
year = "1999",
doi = "10.1097/00002371-199905000-00002",
language = "English (US)",
volume = "22",
pages = "186--211",
journal = "Journal of Immunotherapy",
issn = "1053-8550",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Tumor angiogenesis and endothelial cell modulatory factors

AU - Desai, Sudhen B.

AU - Libutti, Steven K.

PY - 1999

Y1 - 1999

N2 - Angiogenesis is the ability of preexisting vasculature to send out capillary sprouts leading to the formation of new vasculature. It is now a well-accepted idea that progression of solid tumors is intrinsically dependent on angiogenesis for growth of the primary tumor and metastatic lesions. Investigations into tumor angiogenesis have focused on inhibition of tumor neovasculature as yet another possible mechanism for impairing tumor progression. Numerous studies have characterized cellular and molecular factors important to vascular formation and development and have led to the identification and understanding of requisite interactions between endothelium, angiogenic cytokines, and the supporting matrix. These studies have also led to the identification of cytokines involved in the proteolytic disruption of the basement membrane, the migration of endothelial cells, and the proliferation and formation of neoendothelium into functional vasculature. As therapies based on antiangiogenic strategies continue to evolve and clinical trials are conducted, these agents may become an important part of the arsenal against tumor proliferation, especially given their favorable toxicity profile. This review discusses the angiogenic cytokines which have been most intensely studied and the receptors they act upon. Additionally, we discuss select proteases and their importance in the development of neovasculature. A better understanding of these components will help in the development of novel therapeutic strategies.

AB - Angiogenesis is the ability of preexisting vasculature to send out capillary sprouts leading to the formation of new vasculature. It is now a well-accepted idea that progression of solid tumors is intrinsically dependent on angiogenesis for growth of the primary tumor and metastatic lesions. Investigations into tumor angiogenesis have focused on inhibition of tumor neovasculature as yet another possible mechanism for impairing tumor progression. Numerous studies have characterized cellular and molecular factors important to vascular formation and development and have led to the identification and understanding of requisite interactions between endothelium, angiogenic cytokines, and the supporting matrix. These studies have also led to the identification of cytokines involved in the proteolytic disruption of the basement membrane, the migration of endothelial cells, and the proliferation and formation of neoendothelium into functional vasculature. As therapies based on antiangiogenic strategies continue to evolve and clinical trials are conducted, these agents may become an important part of the arsenal against tumor proliferation, especially given their favorable toxicity profile. This review discusses the angiogenic cytokines which have been most intensely studied and the receptors they act upon. Additionally, we discuss select proteases and their importance in the development of neovasculature. A better understanding of these components will help in the development of novel therapeutic strategies.

KW - Endothelial cells

KW - Neovasculature

KW - Tumor angiogenesis

UR - http://www.scopus.com/inward/record.url?scp=0032911811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032911811&partnerID=8YFLogxK

U2 - 10.1097/00002371-199905000-00002

DO - 10.1097/00002371-199905000-00002

M3 - Article

C2 - 10335479

AN - SCOPUS:0032911811

VL - 22

SP - 186

EP - 211

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1053-8550

IS - 3

ER -